ChromaDex Corporation operates as a nutraceutical company. The company offers research and quality control products and services to dietary supplements, food, beverages, cosmetic, and pharmaceutical industries; Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide(NAD) level used for healthy aging; Pterostilbene (pTeroPure), a polyphenol and antioxidant used in health related fields; and Immulina, a spirulina extract and compound, which is used for improving human immune function, as well as developing Pterostilbene and caffeine co-crystal ingredients, and anthocyanins ingredients. It also provides reference standards, materials, and kits to conduct quality control of raw materials and consumer products; and fine chemicals and phytochemicals for research and new product development applications. In addition, the company offers a range of consulting services, including regulatory support, product development, risk management, and litigation support. Further, it assists customers in creating processes for manufacturing natural products using green chemistry, as well as developing phytochemical libraries. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation has a strategic partnership for healthy aging research with the Jiangxi Provincial Government, the People’s Republic of China. ChromaDex Corporation is based in Irvine, California.

Our Co-Founder @JakschFrank discussed the growing body of clinical evidence surrounding #cellularhealth, science-based solutions such as #nicotinamideriboside, and where #NAD+ and healthspan-focused research is headed at the @HOSummit this weekend. #HealthOptimisationSummit

2

The European Food Safety Authority has confirmed nicotinamide riboside (NR) as safe. Not stopping there, EFSA has also found evidence to support the substance as a good source of vitamin B3.

https://t.co/jLCJoZeSLg

ChromaDex founder and executive chairman Frank Jaksch said that the new safety studies conducted on Tru Niagen – the company’s signature NR product – has showed potential for use in personalized nutrition.

https://t.co/YVBrtO2Qj0

"Once the regulatory process is completed, ChromaDex plan to launch its flagship consumer NR product, Tru Niagen in the EU." #cellularhealth #EU #NR

https://t.co/chYz34jrRw

A critical step in the EU regulatory approval process, the European Food Safety Authority (EFSA) issued a positive opinion of Nicotinamide Riboside (NR), commercially known as Niagen at a daily serving of 300 mg in healthy adult populations.

https://t.co/rntXzavUa2

Load More...

FULL NAME*

What's Your Role?*

WORK EMAIL*

COMPANY NAME*

Company Description*

HOW'D YOU HEAR ABOUT US?

DETAILS ABOUT YOUR GOALS

ChromaDex Corporation

10005 Muirlands Boulevard
Suite G
Irvine, CA 92618

+1 (949) 419-0288

www.chromadex.com

September 2019
S M T W T F S
« Aug    
1234567
891011121314
15161718192021
22232425262728
2930  

©2019 ALIGNMT LLC | Alignment Strategy | Mergers & Acquisitions | Investor Relations

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account